Brief: MGC Pharmaceuticals Ltd Says Faced Difficulties In Raising Funds In UK Primarily, And In Australia
26/09/2023 07:40
Sept 26 (Reuters) - MGC Pharmaceuticals Ltd MXC.AX :
* MGC PHARMACEUTICALS LTD - BOARD AND MANAGEMENT HAVE BEEN
FORCED
TO TAKE DECISIVE ACTION AND DESIGN A RESTRUCTURING PLAN
* MGC PHARMACEUTICALS LTD - PLAN WILL REDUCE OUR RELIANCE ON
CONSTANT CAPITAL RAISING AND ALLOW US TO COMPLETE AN 18-MONTH
WORK PLAN
* MGC PHARMACEUTICALS LTD - FACED EXTREME DIFFICULTIES IN
RAISING
FUNDS IN UK PRIMARILY, AND IN AUSTRALIA
Source text for Eikon: ID:nRSZ6570Na
Further company coverage: MXC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Argent BioPharma
See all newsBrief: Argent Biopharma Enters Long Term Aquiol Licensing And Supply Agreement
Brief: Argent Biopharma Secures A$11M Financing Facility To Complete Strategic Acquisition
Brief: Argent Is Growing Through M&A Projected Merged Company Value Of $100M In Ac8 Asset Acquisition
Australia's Argent BioPharma set for best day in a year on AusCann deal
Brief: Argent Biopharma To Acquire Core Operating Assets And IP Portfolio Of Auscann Group